We are committed to helping patients with rare diseases. We identify and develop therapies with the greatest unrealized, long-term potential.

1 day ago · Mereo Advisors, a Bermuda-based firm chaired by former American International Group Inc. Chief Executive Officer Brian Duperreault, has secured more than $700 million to fund its new reinsurance ...

1 day ago · (Bloomberg) -- Mereo Advisors, a Bermuda-based firm chaired by former American International Group Inc. Chief Executive Officer Brian Duperreault, has secured more than $700 million to fund its ...

1 day ago · We’ve heard that the integrated Mereo platform consists of Mereo Insurance Limited and the Mereo ILS Opportunities Fund. As Reinsurance News understands, the former will underwrite a diversified reinsurance portfolio with an equally weighted mix of specialty, property and casualty, and plans to write around $520 million of premium in its ...

1 day ago · Mereo has revealed its additional backers – in addition to cornerstone investor Susquehanna – are Andover and Ares Management, as it launched operations. The business missed the 1 January ...

1 day ago · Mereo is an innovative (re)insurance platform focused on transforming the global property, casualty, and specialty markets. Mereo delivers cutting-edge solutions to meet the evolving needs of the ...

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and...

LONDON, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today...